Dr. Carolina Gandara, Head of Retina Assay Development at Newcells Biotech, leads internal and external projects within the retina platform, overseeing a team of scientists focused on creating ...
Adherent cell assays have lagged behind in automation, slowing drug discovery. Semarion’s SemaCyte® microcarrier platform streamlines these workflows by making adherent cells assay-ready, improving ...
This article is sponsored by BellBrook Labs and INTEGRA BIOSCIENCES. High-throughput screening emerged in the late 1980s, driven by advances in chemistry and genomics. With recent breakthroughs in ...
(MENAFN- GlobeNewsWire - Nasdaq) Demand for ethical, faster safety testing is driving in-vitro assays, with opportunities in 3D cultures, organ-on-chip, AI, high-throughput screening and emerging ...
In the ever-evolving landscape of biomedical research, the need for reliable, consistent, and ready-to-use cell models has never been more critical. ATCC, a leading provider of biological materials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results